Clinical Trials on Cutaneous Patch in Belgium
Total 30 results
-
Institute of Tropical Medicine, BelgiumTerminatedCutaneous LeishmaniasesBelgium
-
Stiefel, a GSK CompanyCompleted
-
EuMelaReg gGmbHRecruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaBelgium
-
Queen Fabiola Children's University HospitalCenter of Human Genetics - ULB in Brussels; Interuniversity Institute of Bioinformatics...UnknownGenodermatosis | Rare Genetic Disease With Cutaneous ExpressionBelgium
-
Universiteit AntwerpenCompleted
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Belgium
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompletedCutaneous Malignant MelanomaBelgium, Hungary
-
Millennium Pharmaceuticals, Inc.Seagen Inc.CompletedMycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
AstraZenecaParexelNot yet recruitingCutaneous Lupus ErythematosusUnited States, Belgium, Germany, Italy, Spain, France, Korea, Republic of, Philippines, United Kingdom, China, Austria, Australia, Netherlands, Bulgaria, South Africa, Taiwan, Denmark, Poland, Serbia, Argentina, Chile, Brazil, Colombia and more
-
Novartis PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma in Situ (CSCCis)Belgium, Australia, United States
-
European Organisation for Research and Treatment...Active, not recruitingCutaneous MelanomaFrance, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Eli Lilly and CompanyActive, not recruitingPancreatic Cancer | Solid Tumor | Cutaneous Melanoma | Microsatellite Instability-High (MSI-H) Solid Tumors | Breast Cancer (HR+HER2-)France, Spain, Belgium, Korea, Republic of, United States, Taiwan, Canada
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Mitsubishi Tanabe Pharma America Inc.CompletedDiffuse Cutaneous Systemic SclerosisSpain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
-
AmgenMerck Sharp & Dohme LLCCompletedHepatocellular Carcinoma | Liver Metastases | Liver Tumors | Cutaneous or Subcutaneous Lymph NodeUnited States, Belgium, Germany, Korea, Republic of, Spain, Austria, Switzerland, Australia, Poland
-
Regeneron PharmaceuticalsSanofiRecruitingCutaneous Squamous Cell CarcinomaUnited States, Australia, Spain, Germany, Belgium, Italy, France, Japan, United Kingdom, Brazil, Canada, Greece, Ireland, New Zealand, Poland, Russian Federation
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
CSL BehringWithdrawnDiffuse Cutaneous Systemic SclerosisBelgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
-
European Organisation for Research and Treatment...TerminatedLymphomaSpain, Finland, France, Germany, Switzerland, Belgium, Netherlands, Italy, Israel, Denmark, Hungary, United Kingdom, Austria
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
4SC AGActive, not recruitingLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeAustria, Spain, Germany, United Kingdom, France, Belgium, Japan, Switzerland, Italy, Poland, Netherlands, Greece
-
PfizerCompletedMetastatic or Unresectable Cutaneous MelanomaUnited States, Spain, Canada, Italy, United Kingdom, Germany, Korea, Republic of, France, Australia, Czechia, Russian Federation, Turkey, Israel, Netherlands, Greece, Hungary, Japan, Portugal, Argentina, Austria, Belgium, Brazil, Po... and more
-
Innate PharmaActive, not recruitingLymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeUnited States, Spain, France, Italy, Belgium, Austria, Germany, Poland
-
Prometheus Biosciences, Inc., a subsidiary of Merck...RecruitingDiffuse Cutaneous Systemic Sclerosis | Interstitial Lung DiseaseUnited States, Australia, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Spain, Switzerland, United Kingdom
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
SOTIO Biotech AGMerck Sharp & Dohme LLCActive, not recruitingHepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Castration-resistant Prostate Cancer | Cutaneous Squamous Cell CarcinomaItaly, Spain, France, Belgium, Czechia, United States, Poland, Georgia, Hungary
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway